Open AccessProgress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study
Author(s) -
Heather Valerio,
Maryam Alavi,
D. B. A. Silk,
Carla Treloar,
Marianne Martinello,
Andrew Milat,
Adrian Dunlop,
Jo Holden,
C. R. Henderson,
Janaki Amin,
Phillip Read,
Philippa Marks,
Louisa Degenhardt,
Jeremy Hayllar,
David Reid,
Carla Gorton,
Thao Minh Lam,
Gregory J. Dore,
Jason Grebely
Publication year - 2020
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa571
Subject(s) - medicine , hepatitis c , hepatitis c virus , odds ratio , viral load , confidence interval , immunology , human immunodeficiency virus (hiv) , virus
Evaluating progress towards hepatitis C virus (HCV) elimination is critical. This study estimated prevalence of current HCV infection and HCV treatment uptake among people who inject drugs (PWID) in Australia.